"I came in about my pores, so why are we not talking about pore treatments?" We hear this question often in clinic. You arrive with a treatment in mind, the one you have read tightens pores, and then hear that we would like to look at the barrier first. Being thrown by that is a fair reaction. This article is not saying your goal is wrong. It is saying that on some skin, the order you take to reach the same goal is different.
Three-Line Summary
- When there are several visible goals at once — pores, pigment, scars — the first thing to settle on sensitive, rosacea-prone skin is not which treatment but which order.
- The fork in the road is not the shape of the pore. It is whether the cause of the lost elasticity is still running right now. Skin where the damage has finished and skin where it is still under way can look much the same and still lead to different choices.
- Moving a visible goal back is a change of timing, not a surrender. Once redness and stinging ease, and recovery from light treatments starts finishing within the range we expected, the order moves forward again.
The Goal Isn't Wrong — Sometimes the Order Is
The situation we meet most often in consultation is the one where there is more than one concern. The cheek pores look wider than they were. There is a mark that could be melasma or could be redness. An old acne scar is still visible. And lately the skin stings after cleansing. Written as a list, it runs to four or five items.
At this point most people naturally order the list by what bothers them most. If pores are the first thing they see in the mirror, pores go first. If pigment is what ruins the photos, pigment goes first. That is a sensible call, and on most skin, working in that order causes no trouble at all.
On some skin, though, that order does not work well. It is because what bothers you most and what has to be dealt with first are not always the same thing.
What changing the order actually changes
We adjust the sequence for practical reasons, not out of an abstract principle. What we have seen repeatedly in clinic is that stacking a damaging treatment onto skin that is already reactive lengthens the recovery. And when recovery lengthens, the gap to the next session slides with it. Sessions planned at four-week intervals stretch to six and then eight, and somewhere in the middle redness comes up and a session gets skipped.
So the choice to move something back often works out as the one that shortens the whole course. Changing the order is less about cutting down the goals than about finding an arrangement that wastes fewer sessions.
"Can't we just do it all at once?"
With several goals in play, the first alternative that comes to mind is doing them together. Layering treatments into a single day looks as though it should compress the timeline. And on skin with stable reactivity, we do sometimes combine treatments of different types within one session.
On reactive skin, though, that combination creates a different problem. When several stimuli overlap on the same day, it becomes hard to tell which one produced the reaction. If redness lingers and you cannot say what needs dialing down, you have nowhere to adjust at the next session, and you end up either repeating the same combination or stopping everything. Splitting the order lightens the recovery load, yes — but the larger point is that it makes the response readable.
To be clear about scope: this article is not about what stages redness treatment moves through, nor about which products suit sensitive skin. It is about the order you line several goals up in when they are all present at once, and only that.
One Fork in the Road — Is the Cause Still Running?
The criterion we actually use to set the order is simpler than you might expect. Is the cause behind the change you see something that has already finished, or something still going on right now?
When the damage has already finished
Intrinsic aging, and the photoaging built up from ultraviolet exposure, both belong here. The two have the same character: structural damage that has already accumulated, from a cause that is now in the past. With photoaging, the collagen and elastin scaffold is already altered, so an approach that induces new collagen is the logical fit.
Methods that trigger a repair response through planned micro-injury work as intended on this kind of tissue — tissue where the damage has stopped. They borrow the body's own process of registering a wound and setting about the repair.
When the damage is still under way
Changes that arise as skin becomes sensitive through repeated irritation and inflammation are a different matter. Here the cause is in the present tense. Inflammation is consuming fibroblasts right now, which means elasticity is still in the process of dropping.
Adding damage to that amounts to laying one more stimulus of the same kind onto a damage mechanism already in motion. It is not merely treating the result while leaving the cause alone. It is closer to pushing in the same direction as the cause.
From the outside, the pores look fairly similar in the two cases. Both have a cheek that has slackened, and both have lost elasticity. But what is happening inside the skin right now runs the opposite way, and that is where the choices split.
The Same Pore Can Be Read in Different Ways
A literature review of the causes of pore enlargement (Lee et al., Dermatol Surg 2016) picks out three factors as clinically relevant: excess sebum production, reduced skin elasticity and tone, and the size of the follicle itself. Of these, the first two are the fork we meet most often in practice.
The sebum pattern
It stands out around the T-zone, closer to round in shape, comes with shine through the day, and feels slick to the touch. Here an approach aimed at sebum production itself comes earlier in the order. Options that work on the sebaceous glands and the keratin layer sit here: Aquapeel, a peel matched to the skin's state, or Gold PTT where acne is part of the picture.
The aging and photoaging laxity pattern
The cheek sags as a whole and the pores stretch along with it, with a history of sun exposure and fine lines visible alongside. Since the damage has already finished, an approach that induces collagen is the first option. Potenza (microneedle RF), the fractional mode of PicoPlus, and depending on the state of the skin the RF-based devices, all belong here.
The inflammation-driven laxity pattern
The pores stretch lengthwise on the inner cheek, are less visible lying down and clearer sitting up. That is to say, they elongate along the line of gravity. What is characteristic is that the pores look stretched even though there is not much sebum. We sometimes see it in people who describe their skin as dry, if anything. It travels with a history of redness, stinging and slow recovery, repeating. This is the pattern the article is about.
| Category | Sebum pattern | Aging and photoaging laxity | Inflammation-driven laxity |
|---|---|---|---|
| Where it shows | Around the T-zone, round | Across the cheek, with sagging | Inner cheek, stretched lengthwise |
| What comes with it | Daytime shine, slick surface | Sun exposure history, fine lines | Redness, stinging, repeated slow recovery |
| What is happening now | Sebum production is high | The damage has already finished | The damage is still under way |
| What comes first | Regulating sebum production itself | Inducing collagen | Barrier stabilization and dermal support |
| Where energy treatments sit | Alongside, depending on the state | First option | Revisited once settled |
One thing worth clearing up here
The main driver of sebum production is androgen, and it is hard to argue that barrier status directly governs how much sebum there is. So the explanation that "my skin got sensitive, so sebum went up, so the pores got bigger" has the direction wrong. On sensitive skin, widened pores are better traced to elasticity than to sebum.
The three patterns also do not divide cleanly. Some people have plenty of sebum and sensitive skin at once, and some carry photoaging and repeated inflammation together. So in practice we look at which side carries more weight and set the order from there.
Why a Barrier Problem Reaches Down Into the Dermis
"What has a weak barrier got to do with wider pores?" We get this question a lot, because a problem in the epidermis and a problem in the dermis feel like separate things. They are connected more closely than you would think.
The structure of the vicious circle
When the barrier is chronically broken down, a cycle forms in which damage and inflammation call each other up. The barrier breaks, external irritants get in easily, that irritation sets off inflammation, and the inflammation obstructs barrier repair again. It does not end with one round of damage; it settles into a state where low-grade inflammation is continuously maintained.
The problem is that this inflammation does not stay in the epidermis. As cytokine load accumulates in the dermis, the explanation is that fibroblast senescence is brought forward. Fibroblasts are the cells that make collagen, so when they tire, the structure of the dermis itself can thin and elasticity can fall.
Animal models of atopic dermatitis show a similar picture. Where Th2-type inflammation persisted, filaggrin expression fell, and at the same time mast cell infiltration and abnormal collagen deposition appeared in the dermis. Which is to say, inflammation in the epidermis and change in the dermis do not run separately.
Does lost elasticity really widen pores?
That leaves the question of whether reduced elasticity actually leads to pores, and here there is correlational work with real measurements in humans. In a study measuring skin elasticity with a Cutometer, the R7 parameter showed a statistically significant negative correlation with large pores (r=-0.337, P=0.033), while the R9 parameter showed a positive correlation (r=0.54, P<0.001). That is, the lower the elasticity, the larger the pores measured, and the authors concluded that improving elasticity could be a fundamental strategy for reducing both pore size and pore count.
In skin with advanced aging and photodamage, as the collagen and elastin scaffold breaks down, expression of MAGP-1 — involved in forming the elastic fibers around the pore — has also been reported to fall (Zheng et al., Clin Cosmet Investig Dermatol 2013).
On the level of the evidence
There is one point to be straight about. The account of barrier damage leading to reduced dermal elasticity rests on the mechanistic reasoning of review papers and on animal-model findings. Long-term human follow-up is still thin, and it is worth holding that in mind as you read.
Energy-Based Treatments Aren't Bad — the Timing Is Different
Reading this far, a misunderstanding can form naturally: "So microneedle RF and fractional lasers are dangerous treatments that damage the skin?" They are not.
The damage is the mechanism, not a side effect
Energy-based treatments — microneedle RF such as Potenza, fractional CO2, the fractional mode of PicoPlus — induce collagen during the repair that follows micro-injury. In the process, the lipid structure of the stratum corneum is temporarily disturbed, TEWL rises, and inflammatory signals are released. But this is the intended process, and the change does not last as long as you might imagine.
In a study of microneedle RF, TEWL (transepidermal water loss) rose for one to three days after treatment and was back at baseline by day seven, and no meaningful long-term change was found in measures of skin sensitivity either. Which means that on normal skin, carried out under ordinary settings, barrier damage is temporary and within the range that reverses. Framing it as "energy treatments wreck the barrier" is not accurate.
The skin that data doesn't apply to
What matters is that the recovery data above came from skin with an intact barrier. On skin where the barrier has already weakened and inflammatory reactivity has risen, the response to the same stimulus can be larger and longer-lasting. Redness that lingers, or stinging that runs on beyond expectation, belongs here. There is also a clinical concern on record that microneedle RF can worsen flushing in skin that already has dilated capillaries.
Still, this is a question of conditions, not a contraindication. It is not that you must not have it. It is that the parameters come down, the intervals lengthen, and the order gets adjusted. On normal skin we add a booster to the damage-and-repair stage to push recovery along; on skin that is already damaged, it is better to add no further damage at all, or to move it later in the order.
How We Actually Arrange the Sequence
So on sensitive skin with several goals, we split the list into three groups and arrange it again. Not in order of importance, but in order of what has to come first for the next thing to work.
First — reducing the triggers and lowering reactivity
What comes right at the front is not a treatment but finding and reducing the triggers that are still at work. We go through the products and active ingredients in use, cleansing habits, recent treatment history, and seasonal and environmental factors together. Repeating calming treatments without this step tends to land you back in the same place.
- LDM (low-intensity ultrasound calming) — placed where calming and recovery need support, by a route with a light heat load. It is also relatively easy to fit around the intervals of other treatments.
- V-Beam (595nm pulsed dye) — where redness and dilated vessels carry a heavy load, this becomes the option for bringing the vascular side down first. Here too, intensity and interval are set conservatively, reading the reactivity.
- PDT and Gold PTT — if acne inflammation is present and forms one axis of the sensitivity, clearing that side first comes earlier in the order.
- Aquapeel and peels — only where keratin and sebum load overlap, placed carefully with the intensity and frequency dialed down. Repeating them at customary intensity on reactive skin can tip toward irritation instead.
Next — supporting the dermis without adding damage
Once reactivity has come down to a degree, we move on to filling the dermis without causing damage. Two categories come early here.
- Rejuran Healer (PN) — the data on polynucleotide is relatively plentiful. In a mouse model where atopic dermatitis was induced with DNCB, topical PN significantly reduced TEWL and serum IgE, and epidermal and dermal thickness and mast cell counts fell along with them. Because it addresses the barrier side while offering a little volume effect as well, we place it early for pores on damaged skin. Conversely, we do not use it as a first choice for improving pores on normal skin.
- Re2O and CellREDM — hADM (ECM) products, which replenish decellularized extracellular matrix directly into the dermis. Rather than inducing collagen production, the idea is to supply the missing structural material itself, so the mechanism is a different one. It can be an approach from another direction for the elasticity around the pores. That said, the published work on it is relatively limited, so the level of evidence sits below that for PN, and that is worth factoring in.
Not every injectable carries the same load just because it is an injection. Even a method that looks light, such as needle-free injection (Synerjet), can make an irritant of the pressure itself, so on reactive skin we set the intensity and the area lower.
Last — the goal you came in for
Pores, pigment, scars — the reason you came to the clinic in the first place sits here. Placing it later does not make it the less important goal. The order falls this way because the two stages before it determine what this stage produces. Once reactivity settles, the options you were considering all along — Potenza (microneedle RF), PicoPlus, fractional CO2 — come back into the frame under the same conditions.
How we set sessions and intervals
In this arrangement, sessions and intervals follow what the recovery from the last session showed rather than a table decided in advance. On sensitive skin, the same treatment at the same intensity takes a different length of time to recover from in different people, and a different length in the same person from one season to the next.
So the first session often starts deliberately at a low intensity. Not to get less out of it, but to establish the range that particular skin reacts across first. What that one session tells us becomes the basis for setting intensity and intervals afterwards, and as a result it reduces how often a plan stalls midway. Sessions, intervals and maintenance timing are agreed together before the first treatment, on the understanding that they may be adjusted as things progress.
What Moves Back, and Why
Setting out which treatments move back makes the criterion clearer. They have one thing in common: they are treatments that use damage or inflammation as their working principle.
Treatments that work through planned damage
Potenza (microneedle RF), fractional CO2 and the fractional mode of PicoPlus belong here. As we saw, on normal skin the effect on the barrier is within the range that reverses, but on skin with raised reactivity, redness and stinging can run longer under the same conditions. So we either lower the intensity and lengthen the intervals, or move the order back altogether.
Treatments that work through intended inflammation
Collagen-inducing products such as Juvelook Volume (PDLLA), Sculptra (PLLA) and Radiesse (CaHA) work a little differently. The response begins as the immune system recognizes the particles placed in the dermis as foreign material, and the low-grade inflammatory response this generates leads on to macrophage differentiation and fibroblast activation, which induces collagen and elastin synthesis. The effect itself, in other words, leans on inflammation that was intended.
On normal skin this response occurs within a predictable range. But on skin where inflammatory reactivity is already elevated, we find ourselves considering the chance that the response to the same stimulus falls outside the normal range — erythema that runs long, or swelling that stays beyond expectation. For reference, collagen-inducing treatments themselves are advised to be avoided or postponed on areas with active infection or ongoing inflammation such as eczema or psoriasis.
One thing to be clear about
There is one thing to say plainly. No clinical trial has been identified that directly compared this category against other materials on sensitive skin and found it inferior. This is an inference that caution is warranted by mechanism, not a proven conclusion. Moving foreign-body-response treatments back is reasonable mechanistically but has not been confirmed by comparative clinical trials, and we think the side doing the explaining should be the one to say so first.
Signals to Bring the Order Forward, Signals to Step It Back
The question we are asked most comes down to this: "So when can I have the treatment I originally wanted?" It would be convenient if there were a set period on the calendar, but in practice we judge by the state of the skin.
Signals that the order can move forward
- Whether day-to-day redness and stinging have visibly eased — we look at whether both how often the skin flushes during the day and how long it lasts are coming down together.
- Whether cleansing or using your products stings less than it used to — the reference point is the reaction to the same products.
- Whether recovery from a light treatment finishes within the expected range — how a calming-stage or low-intensity treatment recovers, and whether it wraps up as planned, is the practical test.
None of these three is decided by detailed imaging or a number from a particular device. They have to be judged by putting subjective symptoms and the visible state of the skin together, which is why we check them with you in consultation. Once the three are reasonably in order, the same approach used for the aging and photoaging laxity pattern becomes available from there.
Signals that the order has to step back
There are also times when a plan already under way returns to an earlier stage. If the following pattern appears, we reset the intensity and the order.
- Redness after treatment lasting longer than usual — if you had the same treatment under the same conditions and the recovery period has visibly lengthened, we read that as a signal.
- The skin not returning to where it was before the next session — if the starting line keeps sliding back even as intervals lengthen, we revisit the order itself.
- Stinging or burning appearing for the first time, or becoming more frequent — if a symptom that was not there has appeared, we look again at the triggers before the intensity.
- The result staying the same while only the recovery lengthens — this can mean the recovery is not keeping pace with the damage.
Pigment and scars follow the same principle
This article has used pores as the example, but the criterion applies unchanged to other goals. Where pigment is the goal, skin with inflammation still rising and falling readily sets up a pattern in which the marks come back. Redness itself can also read as pigment, so settling what the goal actually is comes earlier in the order. The same holds for scars: treatments that work on structure assume a capacity for recovery in the surrounding tissue, so the conditions are better once reactivity has settled.
Finally
Most people are a little taken aback when we go through this in clinic. You came in thinking about a treatment known to be good for pores and are hearing something else, so of course you are. We understand that completely. Which is why it bears saying once more: you are not being told you can never have it. It is only that the order moves back.
And the judgment set out today is not an established protocol. It is the most reasonable direction we can build from the evidence available now. The reasoning about order is an inference assembled from separate pieces of mechanistic evidence, and no comparative clinical trial has yet tested it directly. It may change as further research comes in, and we think it is right to tell you that much too.
One more thing: skin condition, barrier function and degree of inflammation vary widely between people. Even with the same sequence applied, the course and the time it takes can differ, so individual results vary. Energy-based treatments can cause redness, swelling, pigment change and, rarely, scarring; injectable treatments carry the possibility of bruising, nodules, swelling and infection; and where the barrier is damaged, these reactions can be larger or last longer. This is why an assessment of the skin's state before treatment is necessary.
From Consultation to Treatment
A board-certified dermatologist examines you directly, identifies the layer the cause sits in, decides the device and the parameters, and the same dermatologist carries on to perform the treatment. This is not a structure in which a consultant recommends the treatment.
Sessions, intervals, maintenance timing and cost are agreed together before the first treatment.
Frequently Asked Questions
- If we delay the order, doesn't the whole thing just take longer?
- More often it has gone the other way. Stacking a damaging treatment onto reactive skin lengthens the recovery, the gap to the next session keeps sliding, and the total time ends up longer. Think of it as choosing the shorter route to the destination. You are not being told you can never have it.
- How long do I have to wait before I can have the treatment I originally wanted?
- We judge it by the state of the skin, not by a set period on the calendar. Whether day-to-day redness and stinging have visibly eased. Whether cleansing or using your products stings less than it used to. Whether a light treatment finishes recovering within the range we expected. How long that takes varies a great deal between individuals.
- Juvelook and Sculptra are meant to build collagen too. Why do those move back?
- In this category the particles placed in the dermis are recognized by the immune system, and the low-grade inflammation that follows is what leads on to collagen synthesis. The effect itself leans on inflammation that was intended. On skin where inflammatory reactivity is already elevated, that makes us think about the chance of a response landing outside the expected range. This is caution based on mechanism, though, not a conclusion confirmed by comparative clinical trials.
- If I have Rejuran, will my pores improve along with everything else?
- It is not a treatment that narrows pores directly. It is closer to a sequence: the barrier and the inflammation settle, the dermis around the pores improves, and as a result the pores draw less attention. No study has directly confirmed that PN reduces pore size, so we do not use it as a first choice for pores on normal skin. We place it early for pores on skin with a damaged barrier.
- So what do you look at for the treatments that come first?
- Clearing out the triggers comes right at the front, and after that a calming step with a light heat load, such as LDM ultrasound. Where redness and vascular load are heavy we bring in V-Beam, and where acne is part of the picture we place PDT or Gold PTT according to the state of the skin. When the dermis needs support, we look first at the options that fill without adding damage — Rejuran Healer (PN), or Re2O and CellREDM (hADM/ECM).
- Then why do you read my skin differently?
- Because that recovery data came from skin with an intact barrier. On skin where the barrier is already weak and inflammatory reactivity is running high, the same stimulus can leave redness for longer, or stinging that lasts beyond what you expected. This is not a "you must not have it" conversation. It is a lower the intensity, lengthen the intervals, adjust the order conversation.
- Are Potenza and fractional lasers treatments that damage the skin?
- The damage is the mechanism, not a side effect. They create micro-injury so that collagen forms during the repair that follows. In a study of microneedle RF, TEWL (transepidermal water loss) rose for one to three days after treatment and was back at baseline by day seven. On normal skin, under ordinary settings, we take the effect on the barrier to be largely within the range that reverses.
- If the barrier weakens, does elasticity really drop with it?
- Once the barrier is broken, irritants get in easily, that irritation calls up inflammation, and the inflammation gets in the way of barrier repair again. When that load accumulates as far down as the dermis, the accepted explanation is that the fibroblasts making collagen age ahead of schedule. That said, this part rests on mechanistic reasoning and animal-model findings. Long-term human follow-up is still thin.
- My cheek pores look wider than they used to. How do I tell whether that is sebum or lost elasticity?
- The sebum pattern tends to sit around the T-zone, looks closer to round, and comes with shine through the day. The elasticity pattern stretches lengthwise on the inner cheek, and is less visible lying down than sitting up. Plenty of people have both mixed together, so in practice we look at which side carries more weight and set the order from there.
- Is this my fault? Did I look after my skin badly?
- No, that is not what this means. Skin becomes reactive through a mix of things you never got to choose — the reactivity you were born with, the season and the environment, the treatment history behind you. Resetting the order in clinic is not about assigning a cause to you. It is about wasting fewer sessions from here on.